fullerene c60 has been researched along with Cirrhoses, Experimental Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gharbi, N; Hadchouel, M; Moussa, F; Pressac, M; Szwarc, H; Wilson, SR | 1 |
1 other study(ies) available for fullerene c60 and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
[60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity.
Topics: Animals; Antioxidants; Carbon Tetrachloride; Dose-Response Relationship, Drug; Fullerenes; Liver; Liver Cirrhosis, Experimental; Metabolic Clearance Rate; Nanostructures; Rats; Tissue Distribution; Treatment Outcome | 2005 |